Account
Webinar
07.11.2024
Protected: Breaking new ground: key learnings from...

There is no excerpt because this is a protected post.

Read more
Webinar
10.05.2024
EU HTA: moving from strategy to action

Remap Consulting guides participants through the intricacies of incorporating EU HTA considerations ...

Read more
Webinar
28.02.2024
VPAS is dead, long live VPAG: the impact of the UK...

Webinar: Discussions on the new Voluntary Scheme for Branded Medicines, Pricing, Access and Growth (...

Read more
Webinar
31.10.2023
NICE’s Proportionate Approach to Technology ...

Webinar: Our experts discuss NICE's proportionate approach to technology appraisals and the implicat...

Read more
Webinar
06.10.2023
Orphan Medicine Market Access in Europe

Webinar: Our experts discuss Orphan medicine market access in Europe including the impact of EU HTA ...

Read more
Webinar
27.04.2023
Implications of the EU HTA Process for Manufacture...

Our experts discuss the latest news and updates on the EU HTA process, including implications for ma...

Read more
Webinar
08.12.2022
Are you ready for the new EU HTA in 2025?

Webinar: Our experts discuss the latest news and updates on the EU HTA process, including the Joint ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch